founded in 2017, has developed a proprietary machine learning-driven solution for the discovery of best-in-class and first-in-class epitope-selective immunomodulatory therapies for cancer and ...
The development of Epitope Binning-seq represents a major advancement in antibody drug discovery. By providing a rapid, comprehensive, and cost-effective method for evaluating antibody epitope ...
OmniMouse expands the epitope coverage of OmniRat and creates the potential for even broader antibody discovery of single antibodies or antibody cocktails. OmniChicken yields many monoclonal ...